CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model
- PMID: 15593118
- DOI: 10.1002/eji.200324745
CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model
Abstract
Chronic graft rejection mediated by cellular immune responses still poses a serious clinical problem in transplant surgery. Chemokines coordinate the recruitment of leukocytes in inflammatory and immune responses. Their precise functions in the rejection of allografts are still ill defined. This study investigates the role of chemokine receptor 4 (CCR4) in acute and chronic cardiac allograft rejection in mice. Allogeneic hearts were transplanted into CCR4 deficient (CCR4(-/-)) and control recipients. Reverse transcription-PCR showed transcription of macrophage-derived chemokine and thymus and activation-regulated chemokine, the cognate chemokine ligands of CCR4, within the graft. Compared to wild-type controls, acute allograft rejection in CCR4(-/-) recipients was only slightly prolonged. In contrast, in a gallium nitrate chronic cardiac allograft rejection model, cardiac graft survival was significantly prolonged in CCR4(-/-) recipients. A relative increase in the percentage of graft infiltrating CD8(+) T cells in CCR4(-/-) recipients was observed 30 days after transplantation and was accompanied by a decrease in CD4(+) T cells. Moreover, the percentage of NK1.1(+)CD3(+) graft-infiltrating cells was significantly reduced on day 5 and day 30 post transplantation. These findings indicate that CCR4 is involved in the recruitment of NK1.1(+)CD3(+) cells into cardiac allografts and clearly establish an important and novel role for CCR4 in chronic graft rejection.
Similar articles
-
Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.Transplantation. 2000 Jul 15;70(1):168-74. Transplantation. 2000. PMID: 10919596
-
Role of CXCR3 and CCR5 in allograft rejection.Transplant Proc. 2006 Dec;38(10):3221-4. doi: 10.1016/j.transproceed.2006.10.164. Transplant Proc. 2006. PMID: 17175228
-
The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.Eur J Immunol. 2004 Feb;34(2):461-70. doi: 10.1002/eji.200324690. Eur J Immunol. 2004. PMID: 14768051
-
The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection.J Heart Lung Transplant. 1997 Mar;16(3):263-7. J Heart Lung Transplant. 1997. PMID: 9087868 Review. No abstract available.
-
Immunologic mechanisms of cardiac transplant rejection.Cardiovasc Clin. 1990;20(2):87-103. Cardiovasc Clin. 1990. PMID: 2404607 Review.
Cited by
-
Hepatocyte Growth Factor Receptor c-Met Instructs T Cell Cardiotropism and Promotes T Cell Migration to the Heart via Autocrine Chemokine Release.Immunity. 2015 Jun 16;42(6):1087-99. doi: 10.1016/j.immuni.2015.05.014. Epub 2015 Jun 9. Immunity. 2015. PMID: 26070483 Free PMC article.
-
M2 macrophages or IL-33 treatment attenuate ongoing Mycobacterium tuberculosis infection.Sci Rep. 2017 Jan 27;7:41240. doi: 10.1038/srep41240. Sci Rep. 2017. PMID: 28128217 Free PMC article.
-
Chemokines and transplant vasculopathy.Circ Res. 2008 Aug 29;103(5):454-66. doi: 10.1161/CIRCRESAHA.108.182865. Circ Res. 2008. PMID: 18757833 Free PMC article. Review.
-
The Transcription Factor NFATc1 Supports the Rejection of Heterotopic Heart Allografts.Front Immunol. 2018 Jun 12;9:1338. doi: 10.3389/fimmu.2018.01338. eCollection 2018. Front Immunol. 2018. PMID: 29946322 Free PMC article.
-
T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.Br J Pharmacol. 2017 Nov;174(22):3914-3925. doi: 10.1111/bph.13613. Epub 2016 Oct 4. Br J Pharmacol. 2017. PMID: 27590129 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials